NCT04778189View on ClinicalTrials.gov

Effect of Intravenous Dexamethasone on Duration of Hyperbaric Bupivacaine Spinal Anesthesia in Lower Abdominal Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

May 1, 2023

Conditions
Spinal Anesthesia
Interventions
DRUG

Placebo

while patients in group( NS ) will receive 500-mL normal saline IV in 5-10 minutes, after spinal anesthesia

DRUG

i.v dexmethasone

patients in group( SD )will receive 8-mg dexamethasone IV in 500-mL normal saline after spinal anesthesia

Trial Locations (1)

Unknown

faculty of medicine Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04778189 - Effect of Intravenous Dexamethasone on Duration of Hyperbaric Bupivacaine Spinal Anesthesia in Lower Abdominal Surgery | Biotech Hunter | Biotech Hunter